Specialty code 390200000X · Kansas City, KS
NPI
1386211977
Since 2021
Specialty
Specialty code 390200000X
Code 390200000X
Group practices
0
Medicare group memberships
Hospitals
0
Hospital affiliations
3901 Rainbow Blvd, University of Kansas
Kansas City, KS, 66160
Phone (913) 588-5000
Medicare paid
-
No Medicare services published
Medicare patients
-
Drug cost, 2024
$49K
468 prescriptions
Company payments, 2023
$141
From 2 companies
Medicare prescription drug claims, 2024
In 2024, the drug Joy O Ogundare prescribed most often to Medicare patients was Atorvastatin Calcium, with 49 prescriptions and refills. In total Joy O Ogundare wrote 468 Medicare prescriptions that cost $49K.
| Drug |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-12-02.
| Claims |
|---|
| 30-day fills |
|---|
| Patients |
|---|
| Cost |
|---|
| Atorvastatin Calcium Generic | 49 | 131 | 18 | $591 |
| Gabapentin Generic | 17 | 37 | Under 11 | $490 |
| Microgestin Fe Norethindrone-E.Estradiol-Iron | 15 | 15 | Under 11 | $387 |
| Losartan Potassium Generic | 15 | 42 | Under 11 | $146 |
| Lisinopril Generic | 15 | 41 | Under 11 | $151 |
| Ozempic Semaglutide | 15 | 16 | Under 11 | $14K |
| Metformin Hcl Generic | 14 | 28 | Under 11 | $107 |
| Amlodipine Besylate Generic | 14 | 32 | Under 11 | $76.97 |
| Pregabalin Generic | 13 | 17 | Under 11 | $160 |
| Tizanidine Hcl Generic | 12 | 15 | Under 11 | $200 |
| Hydrochlorothiazide Generic | 12 | 32 | Under 11 | $79.93 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 11 | 16 | Under 11 | $330 |
Brand drugs: - claims; generic drugs: 397 claims; opioid claims: 21.
Money and other things of value reported by the companies
In 2023, drug and medical device companies paid Joy O Ogundare $141 ($141 in general payments such as food, travel and fees) from 2 companies. The largest payer was Gilead Sciences, Inc. with $119.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.